IFITM5 mutations and osteogenesis imperfecta
- PMID: 26031935
- DOI: 10.1007/s00774-015-0667-1
IFITM5 mutations and osteogenesis imperfecta
Abstract
Interferon-induced transmembrane protein 5 (IFITM5) is an osteoblast-specific membrane protein that has been shown to be a positive regulatory factor for mineralization in vitro. However, Ifitm5 knockout mice do not exhibit serious bone abnormalities, and thus the function of IFITM5 in vivo remains unclear. Recently, a single point mutation (c.-14C>T) in the 5' untranslated region of IFITM5 was identified in patients with osteogenesis imperfecta type V (OI-V). Furthermore, a single point mutation (c.119C>T) in the coding region of IFITM5 was identified in OI patients with more severe symptoms than patients with OI-V. Although IFITM5 is not directly involved in the formation of bone in vivo, the reason why IFITM5 mutations cause OI remains a major mystery. In this review, the current state of knowledge of OI pathological mechanisms due to IFITM5 mutations will be reviewed.
Keywords: Heterozygous mutation; IFITM5; Osteogenesis imperfecta type V.
Similar articles
-
A nonclassical IFITM5 mutation located in the coding region causes severe osteogenesis imperfecta with prenatal onset.J Bone Miner Res. 2014 Jun;29(6):1387-91. doi: 10.1002/jbmr.2156. J Bone Miner Res. 2014. PMID: 24293101
-
Uncommon IFITM5 mutation associated with severe skeletal deformity in osteogenesis imperfecta.Ann Hum Genet. 2018 Nov;82(6):477-481. doi: 10.1111/ahg.12275. Epub 2018 Jul 24. Ann Hum Genet. 2018. PMID: 30039845
-
IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients.Hum Genomics. 2019 Jun 3;13(1):25. doi: 10.1186/s40246-019-0209-3. Hum Genomics. 2019. PMID: 31159867 Free PMC article.
-
A novel Ser40Trp variant in IFITM5 in a family with osteogenesis imperfecta and review of the literature.Clin Dysmorphol. 2019 Jul;28(3):120-125. doi: 10.1097/MCD.0000000000000279. Clin Dysmorphol. 2019. PMID: 30985308 Review.
-
Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types.Endocr Rev. 2022 Jan 12;43(1):61-90. doi: 10.1210/endrev/bnab017. Endocr Rev. 2022. PMID: 34007986 Free PMC article. Review.
Cited by
-
"Unveiling the genetic symphony: Diversity and expression of chicken IFITM genes in Aseel and Kadaknath breeds".Heliyon. 2024 Sep 10;10(18):e37729. doi: 10.1016/j.heliyon.2024.e37729. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39315180 Free PMC article.
-
The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect.J Clin Invest. 2024 Jun 17;134(15):e170369. doi: 10.1172/JCI170369. J Clin Invest. 2024. PMID: 38885336 Free PMC article.
-
IFITM5-related (type V) osteogenesis imperfecta with evidence of perinatal involvement: A case report.Bone Rep. 2024 Apr 17;21:101766. doi: 10.1016/j.bonr.2024.101766. eCollection 2024 Jun. Bone Rep. 2024. PMID: 38681748 Free PMC article.
-
Osteogenesis imperfecta: a cross-sectional study of skeletal and extraskeletal features in a large cohort of Italian patients.Front Endocrinol (Lausanne). 2024 Jan 11;14:1299232. doi: 10.3389/fendo.2023.1299232. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38274230 Free PMC article.
-
Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches.ACS Pharmacol Transl Sci. 2024 Jan 2;7(1):72-96. doi: 10.1021/acsptsci.3c00324. eCollection 2024 Jan 12. ACS Pharmacol Transl Sci. 2024. PMID: 38230285 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
